Elias K Mai1, Thomas Hielscher2, Jost K Kloth3, Maximilian Merz4, Sofia Shah4, Michaela Hillengass4, Barbara Wagner4, Dirk Hose4, M S Raab4, Anna Jauch5, Stefan Delorme6, Hartmut Goldschmidt4,7, Marc-André Weber3, Jens Hillengass4,6. 1. Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. elias.mai@med.uni-heidelberg.de. 2. Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany. 3. Clinic of Diagnostic and Interventional Radiology, University Hospital of Heidelberg, Heidelberg, Germany. 4. Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. 5. Institute of Human Genetics, University Hospital of Heidelberg, Heidelberg, Germany. 6. Department of Radiology, German Cancer Research Center, Heidelberg, Germany. 7. National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
Abstract
OBJECTIVE: To assess associations between bone marrow infiltration patterns and localization in magnetic resonance imaging (MRI) and baseline clinical/prognostic parameters in multiple myeloma (MM). METHODS: We compared baseline MM parameters, MRI patterns and localization of focal lesions to the mineralized bone in 206 newly diagnosed MM patients. RESULTS: A high tumour mass (represented by International Staging System stage III) was significantly associated with severe diffuse infiltration (p = 0.015) and a higher number of focal lesions (p = 0.006). Elevated creatinine (p = 0.003), anaemia (p < 0.001) and high LDH (p = 0.001) correlated with severe diffuse infiltration. A salt and pepper diffuse pattern had a favourable prognosis. A higher degree of destruction of mineralized bone (assessed by X-ray or computed tomography) was associated with an increasing number of focal lesions on MRI (p < 0.001). Adverse cytogenetics (del17p/gain1q21/t(4;14)) were associated with diffuse infiltration (p = 0.008). The presence of intraosseous focal lesions exceeding the mineralized bone had a borderline significant impact on prognosis. CONCLUSIONS: Diffuse bone marrow infiltration on MRI correlates with adverse cytogenetics, lowered haemoglobin values and high tumour burden in newly diagnosed MM whereas an increasing number of focal lesions correlates with a higher degree of bone destruction. Focal lesions exceeding the cortical bone did not adversely affect the prognosis. KEY POINTS: • Diffuse MRI correlates with adverse cytogenetics, lowered haemoglobin and high tumour burden. • Higher numbers of MRI focal lesions correlate with increasing degree of bone destruction. • Focal lesions exceeding the cortical bone borderline significantly influence survival. • Moderate/severe diffuse infiltration and more than 23 focal lesions adversely affect survival.
OBJECTIVE: To assess associations between bone marrow infiltration patterns and localization in magnetic resonance imaging (MRI) and baseline clinical/prognostic parameters in multiple myeloma (MM). METHODS: We compared baseline MM parameters, MRI patterns and localization of focal lesions to the mineralized bone in 206 newly diagnosed MM patients. RESULTS: A high tumour mass (represented by International Staging System stage III) was significantly associated with severe diffuse infiltration (p = 0.015) and a higher number of focal lesions (p = 0.006). Elevated creatinine (p = 0.003), anaemia (p < 0.001) and high LDH (p = 0.001) correlated with severe diffuse infiltration. A salt and pepper diffuse pattern had a favourable prognosis. A higher degree of destruction of mineralized bone (assessed by X-ray or computed tomography) was associated with an increasing number of focal lesions on MRI (p < 0.001). Adverse cytogenetics (del17p/gain1q21/t(4;14)) were associated with diffuse infiltration (p = 0.008). The presence of intraosseous focal lesions exceeding the mineralized bone had a borderline significant impact on prognosis. CONCLUSIONS: Diffuse bone marrow infiltration on MRI correlates with adverse cytogenetics, lowered haemoglobin values and high tumour burden in newly diagnosed MM whereas an increasing number of focal lesions correlates with a higher degree of bone destruction. Focal lesions exceeding the cortical bone did not adversely affect the prognosis. KEY POINTS: • Diffuse MRI correlates with adverse cytogenetics, lowered haemoglobin and high tumour burden. • Higher numbers of MRI focal lesions correlate with increasing degree of bone destruction. • Focal lesions exceeding the cortical bone borderline significantly influence survival. • Moderate/severe diffuse infiltration and more than 23 focal lesions adversely affect survival.
Entities:
Keywords:
Bone marrow; Magnetic resonance imaging; Multiple myeloma; Plasma cells; Prognosis
Authors: Jens Hillengass; Kerstin Fechtner; Marc-André Weber; Tobias Bäuerle; Sofia Ayyaz; Christiane Heiss; Thomas Hielscher; Thomas M Moehler; Gerlinde Egerer; Kai Neben; Anthony D Ho; Hans-Ulrich Kauczor; Stefan Delorme; Hartmut Goldschmidt Journal: J Clin Oncol Date: 2010-02-22 Impact factor: 44.544
Authors: Jens Hillengass; Klaus Wasser; Stefan Delorme; Fabian Kiessling; Christian Zechmann; Axel Benner; Hans-Ulrich Kauczor; Anthony D Ho; Hartmut Goldschmidt; Thomas M Moehler Journal: Clin Cancer Res Date: 2007-01-15 Impact factor: 12.531
Authors: L A Moulopoulos; D Gika; A Anagnostopoulos; K Delasalle; D Weber; R Alexanian; M A Dimopoulos Journal: Ann Oncol Date: 2005-08-08 Impact factor: 32.976
Authors: F E Lecouvet; B C Vande Berg; L Michaux; J Malghem; B E Maldague; J Jamart; A Ferrant; J L Michaux Journal: Radiology Date: 1998-12 Impact factor: 11.105
Authors: Tobias Bäuerle; Jens Hillengass; Kerstin Fechtner; Christian M Zechmann; Lars Grenacher; Thomas M Moehler; Heiss Christiane; Barbara Wagner-Gund; Kai Neben; Hans-Ulrich Kauczor; Hartmut Goldschmidt; Stefan Delorme Journal: Radiology Date: 2009-08 Impact factor: 11.105
Authors: Maximilian Merz; Thomas M Moehler; Judith Ritsch; Tobias Bäuerle; Christian M Zechmann; Barbara Wagner; Anna Jauch; Dirk Hose; Christina Kunz; Thomas Hielscher; Hendrik Laue; Hartmut Goldschmidt; Stefan Delorme; Jens Hillengass Journal: Eur Radiol Date: 2015-07-29 Impact factor: 5.315
Authors: Sikander Ailawadhi; Ahmed N Abdelhalim; Lyudmyla Derby; Terry L Mashtare; Kena C Miller; Gregory E Wilding; Ronald A Alberico; Ronald Gottlieb; Donald L Klippenstein; Kelvin Lee; Asher A Chanan-Khan Journal: Cancer Date: 2010-01-01 Impact factor: 6.860
Authors: Jost K Kloth; Jens Hillengass; Karin Listl; Kerstin Kilk; Thomas Hielscher; Ola Landgren; Stefan Delorme; Hartmut Goldschmidt; Hans-Ulrich Kauczor; Marc-André Weber Journal: Int J Cancer Date: 2014-04-17 Impact factor: 7.396
Authors: Robin W Jansen; Paul van Amstel; Roland M Martens; Irsan E Kooi; Pieter Wesseling; Adrianus J de Langen; Catharina W Menke-Van der Houven van Oordt; Bernard H E Jansen; Annette C Moll; Josephine C Dorsman; Jonas A Castelijns; Pim de Graaf; Marcus C de Jong Journal: Oncotarget Date: 2018-04-13
Authors: S C Brandelik; S Skornitzke; T Mokry; S Sauer; W Stiller; J Nattenmüller; H U Kauczor; T F Weber; T D Do Journal: Eur Radiol Date: 2021-03-30 Impact factor: 5.315